MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin

W-M Sun1, W Tao, J-C Li

  • 1Department of General Surgery Breast Ward, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China. miaoyejz@126.com.

Abstract

Insights

This study reveals that miR-296 is significantly decreased in breast cancer (BC) and acts as a tumor suppressor. Restoring miR-296 inhibits BC cell proliferation, invasion, and migration, offering potential therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Breast cancer (BC) is a prevalent global malignancy with incompletely understood progression mechanisms.
  • MicroRNAs (miRNAs) are recognized for their critical roles in tumorigenesis.
  • The specific role of miR-296 in BC development and progression requires further elucidation.

Purpose of the Study:

  • To investigate the expression levels of miR-296 in breast cancer tissues and cell lines.
  • To determine the functional impact of miR-296 on BC cell proliferation, invasion, and migration.
  • To explore the underlying molecular mechanisms by which miR-296 influences BC progression.

Main Methods:

  • Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) for miR-296 expression analysis.
  • In vitro functional assays (MTT, Transwell) to assess proliferation, invasion, and migration.
  • Immunohistochemistry (IHC), Western blot, and Luciferase reporter assays to investigate molecular targets and pathways (FGFR1, Wnt/β-catenin, EMT).

Main Results:

  • miR-296 expression was significantly downregulated in BC tissues and cell lines compared to normal controls.
  • Reduced miR-296 levels correlated with advanced malignant phenotypes and poorer patient prognosis.
  • Restoration of miR-296 suppressed BC cell proliferation, invasion, and migration in vitro and inhibited tumor growth in vivo.
  • miR-296 functions by regulating Fibroblast Growth Factor Receptor 1 (FGFR1), the Wnt/β-catenin signaling pathway, and Epithelial-Mesenchymal Transition (EMT).

Conclusions:

  • miR-296 exhibits significant anti-tumor functions in breast cancer.
  • The findings suggest miR-296 as a potential biomarker for BC prognosis and a novel therapeutic target for BC treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K